Showing posts with label Cannabis Research. Show all posts
Showing posts with label Cannabis Research. Show all posts

Cannabinoids and Bladder Matters

Tuesday, 22 January 2019

“Once again CB2 receptor step up to the plate and appear to be able to mitigate com for table bladder inflammation and urinary frequency. This study leaked out of the University of Wisconsin.”
-   Dr. David Hepburn

Abstract:

UTI, short for Urinary Tract Infection is an infection in any part of your urinary system. While most infections involve the lower urinary tract, the bladder, and the urethra, a urinary tract infection can appear in a number of places including your kidneys, ureters, urethra, and bladder.

Few studies have been conducted on the connection between cannabis and UTIs, but those that have conducted studies have released surprising findings suggesting that Cannabis may treat pain caused by Urinary Tract Infection. In a recent study, published in the American Journal of Clinical and Experimental Urology it was found that CB1R activation, which occurs through the consumption of cannabis can help fight pain arising from cystitis.

Read the full article here:

https://www.marijuanabreak.com/marijuana-uti-remedy

Visit

Dr. Dave Hepburn website: https://doctordavidhepburn.com

Cannabis Research in Tourette Syndrome

Monday, 14 January 2019

“An Israeli study showed that of the patients without syndrome who tolerated cannabis treatment, many experienced a reduction in tic severity, better sleep and improved mood.”
-     Dr. David Hepburn

Abstract:

Patients with Gilles de la Tourette syndrome (GTS) experience reduced function and impaired quality of life. The current medical treatments for this syndrome can cause significant side effects and offer partial symptomatic relief.

In a few small trials medical cannabis (MC) has been suggested to offer symptomatic relief with a relatively benign side effect profile. We conducted a real-life assessment of clinical benefit and adverse effects of chronic MC treatment among patients with GTS.

Forty-Two GTS patients (33 males, mean age 34.5) were interviewed for this study. The total global impression score of efficacy was 3.85 out of a total of 5 possible points. Patients reported during the free discussion part of the interview about a reduction in tic severity, better sleep and improved mood as positive effects of MC.

Thirty-eight patients reported any kind of benefit from treatment while 10 patients with more than one year of consumption elected to stop treatment with MC for various reasons including severe side effects as psychosis in one patient.

Read the full article here:


Dr. Dave Hepburn website: https://doctordavidhepburn.com

Related Posts Plugin for WordPress, Blogger...